贾凌云

个人信息Personal Information

教授

博士生导师

硕士生导师

主要任职:生物工程学院院长、党委副书记

性别:女

毕业院校:大连理工大学

学位:博士

所在单位:生物工程学院

学科:生物工程与技术. 生物化工

办公地点:知微楼519房间

电子邮箱:lyjia@dlut.edu.cn

扫描关注

论文成果

当前位置: 贾凌云 >> 科学研究 >> 论文成果

Identification of a New Function of Cardiovascular Disease Drug 3-Morpholinosydnonimine Hydrochloride as an Amyloid-beta Aggregation Inhibitor

点击次数:

论文类型:期刊论文

发表时间:2017-01-01

发表刊物:ACS OMEGA

收录刊物:PubMed、SCIE

卷号:2

期号:1

页面范围:243-250

ISSN号:2470-1343

摘要:Cardiovascular disease (CVD) and Alzheimer's disease (AD) have a mutual cause-and-effect relationship, and they share some common risk factors. Although numerous Food and Drug Administration (FDA)-approved drugs have been developed for CVD treatment, no drugs are clinically available for AD treatment. Given the common disease-causing factors and links between the two diseases and the well-demonstrated drugs for CVD, we propose to re-examine the new potential of the existing CVD drugs as amyloid-beta (A beta) inhibitors. 3-Morpholinosydnonimine hydrochloride (SIN-1) is an FDA-approved drug for inhibiting platelet aggregation in CVD. Herein, we examine the inhibition activity of SIN-1 on the aggregation and toxicity of A beta(1-42) using combined experimental and computational approaches. Collective experimental data from ThT, circular dichroism, and atomic force microscopy demonstrate that SIN-1 can effectively inhibit amyloid formation at every stage of A beta aggregation by prolonging lag phase, slowing down aggregation rate, and reducing final fibril formation. The cell viability assay also shows that SIN-1 enables the protection of SH-SY5Y cells from A beta-induced cell toxicity. Such an inhibition effect is attributed to interference with the structural transition of A beta toward a beta-sheet structure by SIN-1. Furthermore, molecular dynamic simulations confirm that SIN-1 preferentially binds to the C-terminal beta-sheet grooves of an A beta oligomer and consequently disrupts the beta-sheet structure of A beta and A beta-A beta association, explaining experimental observations. This work discovers a new function of SIN-1, making it a promising compound with dual protective roles in inhibiting both platelet and A beta aggregations against CVD and AD.